| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Mr. En-Ping Lin CEO | TWSE Exchange | TW0003008009 ISIN |
| TW Country | - Employees | 19 Mar 2026 Last Dividend | 10 Aug 2009 Last Split | - IPO Date |
SCI Pharmtech, Inc. is a multifaceted company that focuses on the research and development, manufacture, and sale of active pharmaceutical ingredients (APIs), intermediates, and specialty chemicals. Founded in 1987 and headquartered in Taoyuan City, Taiwan, SCI Pharmtech, Inc. has established its presence not only domestically but also on a global scale. The company is recognized for its wide range of high-quality pharmaceutical products that cater to the needs of the pharmaceutical industry. Additionally, SCI Pharmtech, Inc. offers custom manufacturing services, indicating a flexible approach to meeting the diverse needs of its clientele. The company enjoys a broad international market, extending its sales network to Italy, China, the United States, Germany, Taiwan, Switzerland, Spain, Japan, the Netherlands, and beyond.